SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-14-043197
Filing Date
2014-07-15
Accepted
2014-07-15 17:14:43
Documents
1
Group Members
CORA MADSENFLORIAN SCHONHARTINGNB PUBLIC EQUITY KOMPLEMENTAR APS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A v383916_sc13da.htm SC 13D/A 69255
  Complete submission text file 0001144204-14-043197.txt   71044
Mailing Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5 6047077000
QLT INC/BC (Subject) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43381 | Film No.: 14976501
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address OSTERGADE 5 3RD FLOOR DK-1100 COPENHAGEN K G7 -----
Business Address OSTERGADE 5 3RD FLOOR DK-1100 COPENHAGEN K G7 ----- 45 70 20 12 63
NB Public Equity K/S (Filed by) CIK: 0001451330 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A